Effect of vascular amyloid on white matter disease is mediated by vascular dysfunction in cerebral amyloid angiopathy.


Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 29 1 2022
medline: 18 6 2022
entrez: 28 1 2022
Statut: ppublish

Résumé

We postulated that vascular dysfunction mediates the relationship between amyloid load and white matter hyperintensities (WMH) in cerebral amyloid angiopathy (CAA). Thirty-eight cognitively healthy patients with CAA (mean age 70 ± 7.1) were evaluated. WMH was quantified and expressed as percent of total intracranial volume (pWMH) using structural MRI. Mean global cortical Distribution Volume Ratio representing Pittsburgh Compound B (PiB) uptake (PiB-DVR) was calculated from PET scans. Time-to-peak [TTP] of blood oxygen level-dependent response to visual stimulation was used as an fMRI measure of vascular dysfunction. Higher PiB-DVR correlated with prolonged TTP (r = 0.373, p = 0.021) and higher pWMH (r = 0.337, p = 0.039). Prolonged TTP also correlated with higher pWMH (r = 0.485, p = 0.002). In a multivariate linear regression model, TTP remained independently associated with pWMH (p = 0.006) while PiB-DVR did not (p = 0.225). In a bootstrapping model, TTP had a significant indirect effect (ab = 0.97, 95% CI: 0.137-2.461), supporting that the association between PiB-DVR and pWMH is mediated by TTP response. There was no longer a direct effect independent of the hypothesized pathway. Our study suggests that the effect of vascular amyloid load on white matter disease is mediated by vascular dysfunction in CAA. Amyloid lowering strategies might prevent pathophysiological processes leading to vascular dysfunction, therefore limiting ischemic brain injury.

Identifiants

pubmed: 35086372
doi: 10.1177/0271678X221076571
pmc: PMC9207495
doi:

Substances chimiques

Amyloid 0
Amyloidogenic Proteins 0
Aniline Compounds 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1272-1281

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS083711
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG026484
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS096730
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS114526
Pays : United States

Références

J Cereb Blood Flow Metab. 2016 Jan;36(1):40-54
pubmed: 25944592
Neurology. 2017 Jun 6;88(23):2162-2168
pubmed: 28476760
Stroke. 2018 Jun;49(6):1515-1517
pubmed: 29695464
J Cereb Blood Flow Metab. 2018 Feb;38(2):241-249
pubmed: 28318355
Ann Neurol. 2008 Nov;64(5):587-91
pubmed: 19067370
Neurology. 2016 Nov 8;87(19):2043-2049
pubmed: 27605173
Neurology. 2012 Jul 24;79(4):320-6
pubmed: 22786597
Ann Clin Transl Neurol. 2019 Mar 18;6(4):795-806
pubmed: 31020004
Neurology. 2004 Nov 9;63(9):1606-12
pubmed: 15534243
Lancet Neurol. 2016 Jul;15(8):811-819
pubmed: 27180034
Nat Rev Neurol. 2020 Jan;16(1):30-42
pubmed: 31827267
Brain. 2016 Feb;139(Pt 2):563-77
pubmed: 26493635
Neurology. 2015 Jul 7;85(1):63-70
pubmed: 26062629
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
Behav Res Methods. 2008 Aug;40(3):879-91
pubmed: 18697684
Neurology. 2020 Aug 4;95(5):e554-e562
pubmed: 32611644
JAMA Neurol. 2016 Aug 1;73(8):969-76
pubmed: 27295605
Nature. 1996 Mar 14;380(6570):168-71
pubmed: 8600393
Neurology. 2021 Mar 23;96(12):e1646-e1654
pubmed: 33536272
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Behav Res Methods Instrum Comput. 2004 Nov;36(4):717-31
pubmed: 15641418
Lancet Neurol. 2009 Feb;8(2):165-74
pubmed: 19161908
Neurology. 2010 Feb 9;74(6):487-93
pubmed: 20142615
Lancet Neurol. 2017 Sep;16(9):730-740
pubmed: 28716371
J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):982-994
pubmed: 28844070
Neurology. 2008 Oct 28;71(18):1424-30
pubmed: 18955685
J Neurochem. 2012 Nov;123 Suppl 2:39-51
pubmed: 23050641
Neurology. 2013 Nov 5;81(19):1659-65
pubmed: 24097810
Ann Neurol. 2012 Jul;72(1):76-81
pubmed: 22829269
Lancet Neurol. 2016 Jul;15(8):820-829
pubmed: 27133238
Brain. 2015 Jan;138(Pt 1):179-88
pubmed: 25367025
Neurology. 2001 Feb 27;56(4):537-9
pubmed: 11222803
J Neurochem. 2018 Mar;144(5):651-658
pubmed: 28833176
Stroke. 2020 Jan;51(1):29-37
pubmed: 31752614
Ann Neurol. 2010 Oct;68(4):545-8
pubmed: 20865701
Lancet Neurol. 2017 Feb;16(2):115-122
pubmed: 27989553
Ann Neurol. 2013 Apr;73(4):529-36
pubmed: 23424091
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9735-40
pubmed: 10944232
Neuroimage. 2004 Oct;23(2):724-38
pubmed: 15488422
Brain. 2015 Aug;138(Pt 8):2126-39
pubmed: 26115675

Auteurs

Elif Gokcal (E)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Mitchell J Horn (MJ)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

J Alex Becker (JA)

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.

Alvin S Das (AS)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Kristin Schwab (K)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Alessandro Biffi (A)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Natalia Rost (N)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Jonathan Rosand (J)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Anand Viswanathan (A)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Jonathan R Polimeni (JR)

Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA.

Keith A Johnson (KA)

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.

Steven M Greenberg (SM)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

M Edip Gurol (ME)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH